Nexpro MUPS Tablet 40 mg contains Esomeprazole, formulated as a Multiple Unit Pellet System (MUPS) to provide potent and sustained suppression of gastric acid. Esomeprazole is a proton pump inhibitor (PPI) widely used to manage acid-related gastrointestinal disorders such as gastroesophageal reflux disease (GERD), peptic ulcers, erosive esophagitis, and Zollinger-Ellison syndrome.

The MUPS formulation allows the tablet to disintegrate into multiple micro-pellets that resist stomach acid, releasing the drug in the small intestine for optimal absorption and efficacy. This design enhances bioavailability, provides consistent plasma levels, and ensures prolonged acid suppression, making Nexpro MUPS 40 mg suitable for patients with moderate to severe acid-related conditions or for those requiring long-term therapy.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

Each tablet contains:

• Esomeprazole 40 mg (MUPS preparation)

Mechanism of Action

Esomeprazole selectively inhibits the H+/K+ ATPase enzyme (proton pump) in the parietal cells of the stomach, which is responsible for the final step in acid production. By blocking this enzyme, Nexpro MUPS 40 mg significantly reduces gastric acid secretion, leading to:

• Relief from heartburn, acid regurgitation, and gastric discomfort

• Healing of erosive esophagitis and peptic ulcers

• Prevention of acid-related complications such as bleeding, ulceration, and mucosal erosion

The MUPS formulation ensures the drug bypasses stomach acidity and is absorbed efficiently in the small intestine, providing a longer duration of action and improved therapeutic outcomes.

Indications

Nexpro MUPS Tablet 40 mg is indicated for:

• Gastroesophageal reflux disease (GERD)

• Healing of erosive esophagitis

• Treatment of gastric and duodenal ulcers

• Zollinger-Ellison syndrome and other hypersecretory conditions

• Prevention of NSAID-induced gastric ulcers

• Maintenance therapy following healing of erosive esophagitis

It is suitable for adult patients and should be used under medical supervision.

Dosage and Administration

The recommended dosage should be individualized based on the patient’s condition and response. Typically, Nexpro MUPS 40 mg is taken once daily, 30–60 minutes before a meal, preferably in the morning.

The tablet should be swallowed whole with water. Crushing, chewing, or splitting the tablet is not recommended, as this may compromise the MUPS coating and reduce efficacy. Consistent daily intake ensures maximum therapeutic benefit.

Benefits

• Strong and sustained relief from acid-related symptoms

• Promotes healing of gastric and esophageal mucosa

• Prevents complications associated with excessive gastric acid

• MUPS formulation ensures improved absorption and bioavailability

• Convenient once-daily dosing for enhanced patient adherence

Possible Side Effects

Nexpro MUPS 40 mg is generally well-tolerated. Common side effects may include:

• Headache

• Nausea

• Diarrhea or constipation

• Abdominal discomfort

• Flatulence

Rare but serious side effects may include severe allergic reactions, liver dysfunction, low magnesium levels, or vitamin B12 deficiency with prolonged use. Immediate medical attention is advised if symptoms such as severe diarrhea, irregular heartbeat, or jaundice occur.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Precautions and Warnings

• Use cautiously in patients with liver or kidney impairment.

• Long-term therapy may require monitoring of magnesium, calcium, and vitamin B12 levels.

• Inform the physician about all concomitant medications to prevent potential interactions.

• Pregnant or breastfeeding women should use the medication only under strict medical supervision.

Storage

Store below 30°C in a dry place, protected from light and moisture. Keep out of reach of children.

Nexpro MUPS Tablet 40 mg offers potent and sustained acid suppression through its advanced MUPS technology, promoting healing, symptom relief, and long-term protection against acid-related gastrointestinal disorders under proper medical guidance.